Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Public ClinicalTrials.gov record NCT01497899. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Study identification
- NCT ID
- NCT01497899
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 279 participants
Conditions and interventions
Conditions
Interventions
- E/C/F/TAF Drug
- E/C/F/TAF Placebo Drug
- E/C/F/TDF Drug
- E/C/F/TDF Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 27, 2011
- Primary completion
- Oct 16, 2012
- Completion
- Aug 21, 2016
- Last update posted
- Nov 18, 2018
2011 – 2016
United States locations
- U.S. sites
- 40
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham (UAB) | Birmingham | Alabama | 35233 | — |
| Spectrum Medical Group | Phoenix | Arizona | 85012 | — |
| AHF Research Center | Beverly Hills | California | 90211 | — |
| Kaiser Permanente | Los Angeles | California | 90027 | — |
| Peter J. Ruane, MD, Inc. | Los Angeles | California | 90036 | — |
| Anthony Mills MD, Inc | Los Angeles | California | 90069 | — |
| East Bay AIDS Center | Oakland | California | 94609 | — |
| St. Joseph Heritage Healthcare | Orange | California | 92869 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| Kaiser Permanente Medical Group | Sacramento | California | 95825 | — |
| La Playa Medical Group and Clinical Research | San Diego | California | 92103 | — |
| Metropolis Medical | San Francisco | California | 94107 | — |
| Kaiser Permanente Medical Group-Clinical Trials Unit | San Francisco | California | 94118 | — |
| Apex Research, LLC | Denver | Colorado | 80220 | — |
| Dupont Circle Physician's Group | Washington D.C. | District of Columbia | 20009 | — |
| Whitman-Walker Health | Washington D.C. | District of Columbia | 20009 | — |
| Capital Medical Associates, PC | Washington D.C. | District of Columbia | 20036 | — |
| Gary J. Richmond,M.D.,P.A. | Fort Lauderdale | Florida | 33316 | — |
| Wohlfeiler, Piperato and Associates, LLC | Miami Beach | Florida | 33139 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| IDOCF/ValuhealthMD, LLC | Orlando | Florida | 32806 | — |
| St. Joseph's Comprehensive Research Institute | Tampa | Florida | 33614 | — |
| Infectious Disease Specialists of Atlanta | Decatur | Georgia | 30033 | — |
| Mercer University Mercer Medicine | Macon | Georgia | 31201 | — |
| Howard Brown Health Center | Chicago | Illinois | 60613 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Be Well Medical Center | Berkley | Michigan | 48072 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Hennepin County Medical Center | Minneapolis | Minnesota | 55415 | — |
| Central West Clinical Research Inc | St Louis | Missouri | 63108 | — |
| North Shore University Hospital / Division of Infectious Diseases | Manhasset | New York | 11030 | — |
| ID Consultants, P.A. | Charlotte | North Carolina | 28209 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| University of South Carolina School of Medicine Division of Infectious Disease | Columbia | South Carolina | 29203 | — |
| Southwest Infectious Disease Clinical Research Inc | Dallas | Texas | 75219 | — |
| Tarrant County Infectious Disease Associates | Fort Worth | Texas | 76104 | — |
| Therapeutic Concepts, PA | Houston | Texas | 77004 | — |
| Gordon E. Crofoot, MD., PA | Houston | Texas | 77098 | — |
| DCOL Center for Clinical Research | Longview | Texas | 75605 | — |
| Peter Shalit, M.D. | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01497899, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2018 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01497899 live on ClinicalTrials.gov.